CymaBay Therapeutics, Inc.

RENAISSANCE TECHNOLOGIES LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/13/2024

Shares

159,950

Value ($000)

3,778

Weight

0.0%

2019 Q4 - 2023 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/13/2024	3,778	0.0%	159,950	12/31/2023
2023 Q3	11/14/2023	1,692	0.0%	113,450	9/30/2023
2023 Q2	8/11/2023	2,957	0.0%	270,020	6/30/2023
2023 Q1	5/12/2023	4,199	0.0%	481,500	3/31/2023
2022 Q4	2/13/2023	3,172	0.0%	505,900	12/31/2022
2022 Q3	11/14/2022	1,718	0.0%	490,800	9/30/2022
2022 Q2	8/12/2022	1,518	0.0%	514,620	6/30/2022
2022 Q1	5/13/2022	1,429	0.0%	459,535	3/31/2022
2021 Q4	2/11/2022	729	0.0%	215,620	12/31/2021
2021 Q3	11/12/2021	1,871	0.0%	512,591	9/30/2021
2021 Q2	8/13/2021	3,472	0.0%	796,220	6/30/2021
2021 Q1	5/13/2021	4,041	0.0%	890,163	3/31/2021
2020 Q4	2/10/2021	2,352	0.0%	409,720	12/31/2020
2020 Q3	11/13/2020	1,151	0.0%	158,920	9/30/2020
2020 Q2	8/13/2020	309	0.0%	88,520	6/30/2020
2019 Q4	2/13/2020	833	0.0%	424,840	12/31/2019